NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.72 +0.70 (+0.90%) GOLD FUTURES
2,392.30 +32.40 (+1.37%) DOW
39,828.37 +270.26 (+0.68%) Bitcoin GBP
51,691.05 +3,311.86 (+6.85%)
PROCEPT BioRobotics Corporation (PRCT)
| Previous close | 65.31 |
| Open | 66.19 |
| Bid | 68.31 x 200 |
| Ask | 68.72 x 200 |
| Day's range | 65.53 - 77.00 |
| 52-week range | 24.83 - 77.00 |
| Volume | |
| Avg. volume | 569,234 |
| Market cap | 3.515B |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.12 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 71.43 |
GlobeNewswirePROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
SAN JOSE, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Leerink Partners Healthcare Crossroads Conference in Austin, Texas. Management is scheduled to present on Wednesday, May 29 at 10:20 a.m. Eastern Time. Additionally, members of management will present at th
- GlobeNewswire
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
Data from the Icahn School of Medicine at Mount Sinai and Potomac Urology presented at the 2024 AUA Annual Meeting highlight Aquablation therapy’s potential to become the new standard of care in BPH for prostates of all sizesSAN JOSE, Calif., May 06, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced long-term, real-world data sho
Simply Wall St.PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Just Reported And Analysts Have Been Lifting Their Price Targets
PROCEPT BioRobotics Corporation ( NASDAQ:PRCT ) just released its latest quarterly results and things are looking...
